Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 14/20 | 0.38 |
| ▸ | CA1 | P00915 | 8/20 | 0.33 |
| ▸ | CA9 | Q16790 | 7/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18126340 | 1.00 | FAAH (0.42) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL18126379 | 0.97 | FAAH (0.39) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL575976 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL4957282 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL2329989 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL29800472 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL2383854 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL1239007 | 0.90 | FAAH (0.54) | FAAHCA2CA1CA9CA12 | |
| SCHEMBL576001 | 0.89 | CA1 (0.33) | FAAHCA2CA1 | |
| Butane SCHEMBL2384367 | 0.87 | FAAH (0.52) | FAAHCA2CA1CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11695155-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20230155178-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20160294008-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-20160294008-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11695155-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | PTPN1, TP53RK, VDAC1 | FAAH 4653/4885CA2 53/4885CA1 70/4885 |
| US-20160294008-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | PTPN1, TP53RK, VDAC1 | FAAH 4644/4885CA2 54/4885CA1 67/4885 |
| US-20230155178-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | PTPN1, TP53RK, VDAC1 | FAAH 4653/4885CA2 53/4885CA1 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.